Leef Brands (LEEEF) FCF Margin (2025 - 2026)

Leef Brands' (LEEEF) quarterly FCF Margin came in at 1.06% in Q1 2026, up 2020.0% year-on-year from 0.05% in Q1 2025, and up 94.99% quarter-over-quarter from 21.26% in Q1 2025.

Leef Brands (LEEEF) FCF Margin (2025 - 2026) Analysis & Trends

Leef Brands has disclosed FCF Margin across 2 years of filings, most recently posting 1.06% for Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -5.22%
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 12.86%
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 46.39%
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 16.78%
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -2.77%
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -429.96%
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 13.24%
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 32.62%
10 Leef Brands - - 4.62 Mn -1.06%

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.06%
Mar 31, 2025 -21.26%